| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/11/1995 | WO1995012677A2 Immunodominant human t-cell epitopes of hepatitis c virus |
| 05/11/1995 | WO1995012676A1 Chimeric proteins comprising borrelia polypeptides: uses therefor |
| 05/11/1995 | WO1995012675A1 A fusion protein and method for making and using same |
| 05/11/1995 | WO1995012674A1 Human kunitz-type protease inhibitors |
| 05/11/1995 | WO1995012673A1 Receptor on the surface of activated t-cells: acts-4 |
| 05/11/1995 | WO1995012672A1 Manufacture and use of polypeptides tagged using binding molecules |
| 05/11/1995 | WO1995012671A1 Helminth parasite antigen with aminopeptidase-like activity |
| 05/11/1995 | WO1995012670A1 Opioid receptor: compositions and methods |
| 05/11/1995 | WO1995012666A1 Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use |
| 05/11/1995 | WO1995012665A1 Embryonic stem cells capable of differentiating into desired cell lines |
| 05/11/1995 | WO1995012663A1 Improved cell cultivation method and medium |
| 05/11/1995 | WO1995012660A2 Recombinant p53 adenovirus methods and compositions |
| 05/11/1995 | WO1995012616A1 Nucleic acid molecules encoding kappa3 opioid receptors, receptors encoded thereby, and uses thereof |
| 05/11/1995 | WO1995012615A1 Antihaemostatic agents from necator americanus |
| 05/11/1995 | WO1995012614A1 Cd6 ligand |
| 05/11/1995 | WO1995012613A1 Metal-bonding cystein-free peptides for diagnosis and therapy, process for producing them and pharmaceutical preparations containing these compounds |
| 05/11/1995 | WO1995012610A1 N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compounds |
| 05/11/1995 | WO1995012609A1 Process for producing a virus-inactivated factor viii-containing fraction by chromatographic methods |
| 05/11/1995 | WO1995012415A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions |
| 05/11/1995 | WO1995012414A1 Novel modified pf4 compositions and methods of use |
| 05/11/1995 | WO1995012410A1 Vaccine design and production |
| 05/11/1995 | WO1995012408A1 Plasmin-independent fibrinolysis |
| 05/11/1995 | WO1995012406A1 Use of urinastatin-like compounds to prevent premature delivery |
| 05/11/1995 | WO1995012392A1 Biochemically active agents for chemical catalysis and cell receptor activation |
| 05/11/1995 | WO1995012313A1 Virus associated multiple sclerosis: treatments, prevention and diagnosis thereof |
| 05/11/1995 | WO1995012309A1 NUCLEIC ACIDS ENCODING [His?5, Trp7, Tyr8¿]-GnRH PREPROHORMONE AND [Ser8]-GnRH PREPROHORMONE AND THEIR USES |
| 05/11/1995 | WO1995012304A1 Salicylic acid binding protein |
| 05/11/1995 | WO1995011305A3 Insecticidal proteins |
| 05/11/1995 | WO1995008628A3 Nucleic acids encoding merosin, merosin fragments and uses thereof |
| 05/11/1995 | DE4334541A1 Layer consisting of a haem protein and application thereof |
| 05/11/1995 | CA2552499A1 Immunodominant human t-cell epitopes of hepatitis c virus |
| 05/11/1995 | CA2175902A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions |
| 05/11/1995 | CA2175806A1 Virus associated multiple sclerosis: treatments, prevention and diagnosis thereof |
| 05/11/1995 | CA2175708A1 Vaccine design and production |
| 05/11/1995 | CA2175692A1 Immunodominant human t-cell epitopes of hepatitis c virus |
| 05/11/1995 | CA2175493A1 Salicylic acid binding protein |
| 05/11/1995 | CA2175454A1 Helminth parasite antigen with aminopeptidase-like activity |
| 05/11/1995 | CA2175328A1 Use of urinastatin-like compounds to prevent premature delivery |
| 05/11/1995 | CA2175247A1 Cd6 ligand |
| 05/11/1995 | CA2175222A1 Immobilized mismatch binding protein for detection or purification of mutations or polymorphisms |
| 05/11/1995 | CA2175209A1 Manufacture and use of polypeptides tagged using binding molecules |
| 05/11/1995 | CA2174533A1 Improved cell cultivation method and medium |
| 05/11/1995 | CA2174244A1 Biochemically active agents for chemical catalysis and cell receptor activation |
| 05/11/1995 | CA2173845A1 Metal-bonding cystein-free peptides for diagnosis and therapy, process for producing them and pharmaceutical preparations containing these compounds |
| 05/11/1995 | CA2173844A1 N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compounds |
| 05/11/1995 | CA2172815A1 Viral vector with bovine viral diarrhea virus (bvdv) antigens |
| 05/11/1995 | CA2135461A1 Promoting elements of chimeric alpha-tubuline genes |
| 05/11/1995 | CA2135330A1 Live vaccine vectors based on mycoplasma gallisepticum and nucleic acid probes therefrom |
| 05/10/1995 | EP0670729A4 Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs. |
| 05/10/1995 | EP0652287A2 Poxviral vectors and their use as a vaccine against feline infectious peritonitis virus disease |
| 05/10/1995 | EP0652286A1 Promoter elements of chimaeric alpha tubulingenes |
| 05/10/1995 | EP0652232A1 P53as protein and antibody therefor |
| 05/10/1995 | EP0652231A1 NON-TOXIC RIBOSOME INACTIVATING PROTEINS (RIPs) WITH TWO CHAINS, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS |
| 05/10/1995 | EP0652230A1 Biologically active bactericidal/permeability-increasing protein fragments |
| 05/10/1995 | EP0652227A1 Method of purifying hydrophobic polypeptide |
| 05/10/1995 | EP0652225A1 Use of D-Gluocopyranosiduronic acids and their derivatives for incorporation into pharmacologically active peptides and their salts |
| 05/10/1995 | EP0652015A2 A sustained release composition comprising a multivalent cation cross-linked algenate combined with a polyacrylic acid |
| 05/10/1995 | EP0652011A1 Prophylactic and remedy for viral diseases in respiratory tract |
| 05/10/1995 | EP0651883A1 Peptides useful as internal standards for microsequencing and methods for their use |
| 05/10/1995 | EP0651820A1 MONOCLONAL ANTIBODIES AGAINST THE $g(a)-TNF TYPE I RECEPTOR, PROCESS FOR THE PRODUCTION AND USE THEREOF |
| 05/10/1995 | EP0651818A1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
| 05/10/1995 | EP0651813A1 A brassica regulatory sequence for root-specific or root-abundant gene expression |
| 05/10/1995 | EP0651812A1 Modular promoter construct |
| 05/10/1995 | EP0651811A1 $i(K. LACTIS) RP28 RIBOSOMAL PROTEIN GENE PROMOTER AND USE THEREOF |
| 05/10/1995 | EP0651810A1 K. lactis pyruvate-decarboxylase promoter gene and use thereof |
| 05/10/1995 | EP0651808A1 Recombinant dna encoding a desulfurization biocatalyst |
| 05/10/1995 | EP0651807A1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
| 05/10/1995 | EP0651806A1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 05/10/1995 | EP0651802A1 Polypeptides having serotoninergic receptor activity (5ht6), nucleic acids coding for said polypeptides, and uses thereof |
| 05/10/1995 | EP0651801A1 Polypeptides having serotoninergique activity (5ht5a), nucleic acids coding for these polypeptides and uses thereof |
| 05/10/1995 | EP0651800A1 Basophil granule proteins |
| 05/10/1995 | EP0651799A1 Fibrin binding domain polypeptides and uses and methods of producing same |
| 05/10/1995 | EP0651798A1 Target antigens of transmission blocking antibodies for malaria parsites |
| 05/10/1995 | EP0651795A1 Method for isolating mutant cells |
| 05/10/1995 | EP0651770A1 Antihemophilic factor stabilization |
| 05/10/1995 | EP0651769A1 Leukaemia inhibitory factor-binding protein |
| 05/10/1995 | EP0651768A1 USE OF p97 AND IRON BINDING PROTEINS AS DIAGNOSTIC AND THERAPEUTIC AGENTS |
| 05/10/1995 | EP0651767A1 Biologically active polypeptides derived from an actinomycete |
| 05/10/1995 | EP0651766A1 BOVINE PANCREATIC TRYPSIN INHIBITOR DERIVED INHIBITORS OF FACTOR Xa |
| 05/10/1995 | EP0651765A1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
| 05/10/1995 | EP0651764A1 Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor. |
| 05/10/1995 | EP0651763A1 Oligopeptide collagen derivatives and their use in secondary cataract prevention |
| 05/10/1995 | EP0651762A1 Method and apparatus for the rapid synthesis of substrate-bound or free peptides or oligonucleotides, flat material synthesized in this way and the use of such material |
| 05/10/1995 | EP0651761A1 Method for modification of recombinant polypeptides |
| 05/10/1995 | EP0651653A1 p53 VACCINE |
| 05/10/1995 | EP0651652A1 Treatment for sensitive teeth |
| 05/10/1995 | EP0651651A1 Amylin antagonists and agonists |
| 05/10/1995 | EP0651646A1 Therapeutic conjugates of toxins and drugs |
| 05/10/1995 | EP0651636A1 Chemotherapy for cancer |
| 05/10/1995 | EP0651633A1 Phosphopeptides for the treatment of dental calculus |
| 05/10/1995 | EP0651609A1 Pasteurella multocida toxoid vaccines |
| 05/10/1995 | EP0491824B1 Human parvovirus b19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines |
| 05/10/1995 | EP0477231B1 Immunoactive peptides and antibodies and their use in anti-allergy treatment |
| 05/10/1995 | EP0424476B1 Antisense oligonucleotides to c-myb proto-oncogene and uses thereof |
| 05/10/1995 | EP0400051B1 Polypeptide compounds having growth hormone releasing activity |
| 05/10/1995 | EP0366718B1 Monoclonal antibodies neutralizing hiv-1 |
| 05/10/1995 | EP0301078B1 Polypeptides with activity against gram-positive and gram-negative bacteria |
| 05/10/1995 | EP0222842B1 Cloning and expression of host-protective immunogens of ibdv |
| 05/10/1995 | EP0208772B1 Test for campylobacter |
| 05/10/1995 | CN1102438A Bifunctional variants of urokinase with improved fibrinolytic properties and thrombin-inhibiting activity |